Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, UK
PROSCAR 5mg film-coated Tablets (finasteride).
| Pharmaceutical Form |
|---|
|
Blue-coloured, apple-shaped, film-coated tablets marked ‘Proscar’ on one side and ‘MSD 72’ on the other. |
Each tablet contains 5 mg of finasteride.
| Active Ingredient | Description | |
|---|---|---|
| Finasteride |
Finasteride is a competitive inhibitor of human 5α-reductase, an intracellular enzyme which metabolises testosterone into the more potent androgen, dihydrotestosterone (DHT). In benign prostatic hyperplasia (BPH), enlargement of the prostate gland is dependent upon the conversion of testosterone to DHT within the prostate. Finasteride is highly effective in reducing circulating and intraprostatic DHT. Finasteride has no affinity for the androgen receptor. |
| List of Excipients |
|---|
|
Cellulose, Microcrystalline (E460) |
Opaque PVC/PE/PVDC blisters lidded with aluminium foil; packs of 28 tablets.
Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, UK
PL 0025/0279
July 1997
| Drug | Countries | |
|---|---|---|
| PROSCAR | Austria, Australia, Brazil, Canada, Germany, Ecuador, Spain, Finland, Hong Kong, Croatia, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
